Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)

CAPS Rating: 3 out of 5

A biotechnology company focused on the discovery and development of small molecule therapeutics for the potential treatment of cancer.

Recs

0
Player Avatar 78taxs (35.08) Submitted: 8/4/2012 5:51:37 PM : Outperform Start Price: $7.04 THLD Score: -42.98

clinicals trials look good.

Featured Broker Partners


Advertisement